查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552910

数位神经生物标记物市场规模、份额、趋势分析报告：按类型、临床实践、最终用途、地区、细分趋势：2024-2030

Digital Neuro Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By End Use, By Region And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

数位神经生物标记市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，预计到 2030 年，全球数位神经生物标记市场规模将达到 28.2 亿美元，预计 2024 年至 2030 年复合年增长率为 25.3%。

该市场受到多种因素的推动，包括神经系统疾病的日益流行、全球老年人口的不断增长、技术进步、个性化医疗的需求以及私营和上市公司对市场投资的增加，从而实现了显着的增长。此外，数位医疗技术的监管核准和报销范围的扩大正在推动数位神经生物标记的采用。监管机构已经认识到这些技术在改善患者治疗效果方面的潜力，从而製定了支持性政策和报销模式。

阿兹海默症、帕金森氏症和多发性硬化症等神经系统疾病的盛行率不断增加，大大推动了对数位神经生物标记的需求。这些复杂的疾病需要准确、持续的监测和早期发现，以有效管理症状并改善患者的治疗结果。数位神经生物标记物透过穿戴式感测器和行动医疗应用等先进技术准确追踪神经功能和疾病进展。透过提供即时资料和见解，这些生物标记能够实现早期疗育和个人化治疗策略，满足及时、有针对性地管理神经系统疾病的迫切需求。例如，美国有近 100 万人患有多发性硬化症 (MS)。根据美国国家多发性硬化症协会估计，全球整体有超过 280 万人患有多发性硬化症。大多数被诊断出患有多发性硬化症的人年龄在 20 至 50 岁之间，但它可以发生在任何年龄。此外，女性多发性硬化症的诊断率高于男性。

神经系统疾病的早期发现和预防变得越来越重要。数位神经生物标记物具有比传统方法更早检测疾病标记物的优势，从而可以及时干预和管理。人工智慧和机器学习的整合也在推动市场成长；例如，2022 年 9 月，Nutromics 从 Dexcom Ventures 获得了 1400 万美元的资金，以推进其「lab-in-a-patch」平台。这项创新技术利用 DNA 感测器来监测各种目标，包括疾病生物标记和治疗药物。此外，将数位神经生物标记物与更广泛的数位健康平台（例如电子健康记录（EHR）和远端医疗）相结合，将提高其效用和可近性。这种整合有助于持续监测和即时资料分析，以改善患者护理和结果。例如，2021 年 10 月，致力于开发先进神经疾病诊断的人工智慧公司 Altoida 开始了为期五年的多中心观察研究。这项广泛的研究将包括数千名处于阿兹海默症各个阶段的患者，旨在提高我们对疾病连续体的理解并提高诊断能力。

主要企业采用各种策略来维持竞争优势，包括合併、收购和产品发布。主要市场参与企业的主要策略倡议包括：

  • 2024 年 4 月，Tris Pharma Inc. 与 Brainaze Ltd. 签订授权合约，成立 Tris Digital Health。新部门将专注于开发和行销用于注意力不足过动症（ADHD）和其他神经系统疾病的数位诊断和治疗产品。
  • 2024 年 3 月，Cumulus Neuroscience 获得创新英国 SBRI（小型企业研究计画）约 125 万美元的津贴。这笔资金将支持人工智慧诊断工具的开发和检验，旨在提高血液生物标记物的准确性。新的人工智慧演算法将血液生物标记与透过 Cumulus 神经评估平台获得的数位生物标记和人口统计资讯相结合。
  • 2024年1月，哈佛大学约翰·A·保尔森工程与应用科学学院、波士顿大学萨金特健康与復健科学学院和哈佛大学维斯研究所的研发科学家开发了一款柔软、可穿戴的机器人，旨在帮助帕金森氏症患者走路更顺畅。这款创新的机器人服装会附着在您的大腿和臀部上，并在您每次摆动双腿时轻轻按压您的臀部。这种支撑使患者能够迈出更大的步伐并变得不那么僵硬，从而提高他们的运动技能和整体行走能力。

数位神经生物标记物市场报告亮点

  • 按类型划分，穿戴式装置领域以 2023 年最高收益占有率41.1% 领先市场。基于行动的应用程式领域预计在预测期内将出现最快的复合年增长率。
  • 根据临床实践，诊断细分市场在 2023 年以 32.23% 的最高收益占有率引领市场。预计监测产业在预测期内将出现最快的复合年增长率。
  • 根据最终用途，医疗保健公司细分市场在 2023 年以 50.7% 的最高收益占有率引领市场。预计医疗保健提供者产业在预测期内将出现最快的复合年增长率。
  • 北美地区在 2023 年以 58.45% 的收益占有率占据市场主导地位。对神经系统疾病诊断的需求不断增加，导致对神经系统生物标记的需求显着增加。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章数位神经生物标记物市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 数位神经生物标记市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 技术时间表和产品平臺分析
    • 案例研究分析/最终使用案例分析

第四章数位神经生物标记市场：按类型估计和趋势分析

  • 细分仪表板
  • 数位神经生物标记市场：类型变异分析
  • 数位神经生物标记市场：按类型分類的展望
  • 穿戴式的
  • 基于行动的应用程式
  • 感应器
  • 其他的

第五章数位神经生物标记市场：临床实践的估计和趋势分析

  • 细分仪表板
  • 数位神经生物标记市场：临床实践变异分析
  • 临床实务展望：数位神经生物标记市场
  • 诊断数位神经生物标记
  • 数位神经生物标记监测
  • 预测和预后数字神经生物标记
  • 其他的

第六章 数位神经生物标记市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 数位神经生物标记市场：最终用途的变异分析
  • 最终用途展望：数位神经生物标记市场
  • 医疗保健公司
  • 医疗服务提供方
  • 付款人
  • 其他的

第七章数字神经生物标记市场：区域估计与趋势分析

  • 区域仪表板
  • 按地区分類的数位神经生物标记市场波动分析
  • 数位神经生物标记市场：按类型、临床实践和最终用途分類的区域估计和趋势分析
  • 2018-2030年市场规模、预测及趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 挪威
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Altoida Inc.
    • Koneksa
    • Biogen Inc.
    • Roche（Navify）
    • NeuraMetrix
    • Merck KGaA
    • Linus Health
    • Neurotrack Technologies, Inc.
    • Huma
    • NeuraLight
Product Code: GVR-4-68040-409-5

Digital Neuro Biomarkers Market Growth & Trends:

The global digital neuro biomarkers market size is anticipated to reach USD 2.82 billion by 2030 and is projected to grow at a CAGR 25.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is witnessing significant growth owing to various factors such as increased prevalence of neurological disorders, rising geriatric population globally, advances in technology, demand for personalized medicine, and increased investment in the market by private and public players. Furthermore, positive regulatory approvals and increasing reimbursement coverage for digital health technologies encourage the adoption of digital neuro biomarkers. Regulatory bodies are recognizing the potential of these technologies to improve patient outcomes, leading to supportive policies and reimbursement models.

The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis is significantly fueling the demand for digital neuro biomarkers. These complex conditions necessitate accurate, continuous monitoring and early detection to manage symptoms effectively and improve patient outcomes. Digital neuro biomarkers, through advanced technologies such as wearable sensors and mobile health applications, offer precise tracking of neurological functions and disease progression. By providing real-time data and insights, these biomarkers enable early intervention and personalized treatment strategies, addressing the critical need for timely and targeted management of neurological conditions. For instance, in the U.S., close to 1 million individuals are impacted by multiple sclerosis (MS). Globally, it is estimated that over 2.8 million people are living with MS, according to the National Multiple Sclerosis Society. While most MS diagnoses occur between the ages of 20 and 50, the condition can affect individuals at any age. In addition, MS is more commonly diagnosed in women compared to men.

There is a growing emphasis on early detection and prevention of neurological diseases. Digital neuro biomarkers offer the advantage of detecting disease markers at an earlier stage than traditional methods, allowing for timely intervention and management. Integration of AI and machine learning is also driving the market growth, for instance, in September 2022, Nutromics secured USD 14 million in funding from Dexcom Ventures to advance its 'lab-in-a-patch' platform. This innovative technology utilizes DNA sensors to monitor a range of targets, including disease biomarkers and challenging-to-dose medications. Moreover, the integration of digital neuro biomarkers with broader digital health platforms, including electronic health records (EHRs) and telemedicine, enhances their utility and accessibility. This integration facilitates continuous monitoring and real-time data analysis, improving patient care and outcomes. For instance, In October 2021, Altoida, Inc., an AI company at developing advanced neurological disease diagnostics, launched a five-year multicenter observational study. This extensive study will involve thousands of patients across all stages of Alzheimer's disease, aiming to enhance the understanding and diagnostic capabilities of the disease continuum.

Key players are adopting various strategies to maintain a competitive edge such as mergers, acquisition, product launches, etc. Some of the key strategic initiatives by the major market players include:

  • In April 2024, Tris Pharma Inc. entered into a licensing agreement with Braingaze Ltd. and established Tris Digital Health. This new division will focus on the development and distribution of digital diagnostic and therapeutic products for attention-deficit/hyperactivity disorder (ADHD) and other neurological health conditions
  • In March 2024, Cumulus Neuroscience was awarded a grant of nearly USD 1.25 million from the Innovate UK SBRI (Small Business Research Initiative). This funding will support the development and validation of an AI diagnostic tool designed to enhance the accuracy of blood biomarkers. The new AI algorithms will integrate blood biomarkers with digital biomarkers-obtained through the Cumulus Neuroassessment Platform-and demographic information
  • In January 2024, Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences, Boston University Sargent College of Health & Rehabilitation Sciences, and the Wyss Institute at Harvard University developed a soft, wearable robot designed to assist individuals with Parkinson's disease in walking more smoothly. This innovative robotic garment, which is worn around the thighs and hips, provides a gentle push to the hips during each leg swing. This support helps the patient achieve a longer stride and reduces instances of freezing, improving mobility and overall walking ability

Digital Neuro Biomarkers Market Report Highlights:

  • Based on type, the wearable segment led the market with the largest revenue share of 41.1% in 2023. The mobile-based application segment is expected to witness at the fastest CAGR over the forecast period.
  • Based on clinical practice, the diagnostic segment led the market with the largest revenue share of 32.23% in 2023. The monitoring segment is expected to witness at the fastest CAGR over the forecast period
  • Based on end use, the healthcare companies segment led the market with the largest revenue share of 50.7% in 2023. The healthcare providers segment is expected to witness at the fastest CAGR over the forecast period
  • North America dominated the market with a revenue share of 58.45% in 2023. The rising need for diagnosing neurological disorders has significantly increased the demand for neurological biomarkers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Clinical Practice
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Clinical practice outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Digital Neuro Biomarkers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Digital Neuro Biomarkers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. Technology Timeline & Product Pipeline Analysis
    • 3.3.4. Case Study Analysis/ End Use Case Analysis

Chapter 4. Digital Neuro Biomarkers Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Digital Neuro Biomarkers Market: Type Movement Analysis
  • 4.3. Digital Neuro Biomarkers Market by Type Outlook (USD Million)
  • 4.4. Wearables
    • 4.4.1. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Mobile based Applications
    • 4.5.1. Mobile based Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sensors
    • 4.6.1. Sensors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Digital Neuro Biomarkers Market: Clinical Practice Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Digital Neuro Biomarkers Market: Clinical Practice Movement Analysis
  • 5.3. Digital Neuro Biomarkers Market by Clinical Practice Outlook (USD Million)
  • 5.4. Diagnostic Digital Neuro Biomarkers
    • 5.4.1. Diagnostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Monitoring Digital Neuro Biomarkers
    • 5.5.1. Monitoring Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Predictive and Prognostic Digital Neuro Biomarkers
    • 5.6.1. Predictive and Prognostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Digital Neuro Biomarkers Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Digital Neuro Biomarkers Market: End Use Movement Analysis
  • 6.3. Digital Neuro Biomarkers Market by End Use Outlook (USD Million)
  • 6.4. Healthcare companies
    • 6.4.1. Healthcare companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Healthcare Providers
    • 6.5.1. Healthcare Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Payers
    • 6.6.1. Payers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Digital Neuro Biomarkers Market movement analysis
  • 7.3. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis by Type, Clinical Practice & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Canada Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Mexico Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. UK Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Germany Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. France Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Italy Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Spain Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Denmark Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Norway
      • 7.5.13.1. Norway Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Sweden
      • 7.5.14.1. Sweden Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Japan Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. China Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. India Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. South Korea Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Australia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Thailand Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Brazil Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Argentina Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. South Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Saudi Arabia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. UAE Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Kuwait Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Altoida Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Koneksa
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Biogen Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Roche (Navify)
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. NeuraMetrix
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Merck KGaA
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Linus Health
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Neurotrack Technologies, Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Huma
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. NeuraLight
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 4. Global digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 5. Global digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 6. North America digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
  • Table 7. North America digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 8. North America digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 9. North America digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 10. U.S. digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 11. U.S. digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 12. U.S. digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 13. Canada digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 14. Canada digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 15. Canada digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 16. Mexico digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 17. Mexico digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 18. Mexico digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 19. Europe digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
  • Table 20. Europe digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 21. Europe digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 22. Europe digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 23. UK digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 24. UK digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 25. UK digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 26. Germany digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 27. Germany digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 28. Germany digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 29. France digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 30. France digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 31. France digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 32. Italy digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 33. Italy digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 34. Italy digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 35. Spain digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 36. Spain digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 37. Spain digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 38. Denmark digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 39. Denmark digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 40. Denmark digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 41. Norway digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 42. Norway digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 43. Norway digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 44. Sweden digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 45. Sweden digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 46. Sweden digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 47. Asia Pacific digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 48. Asia Pacific digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 49. Asia Pacific digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 50. China digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 51. China digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 52. China digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 53. Japan digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 54. Japan digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 55. Japan digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 56. India digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 57. India digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 58. India digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 59. Australia digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 60. Australia digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 61. Australia digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 62. South Korea digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 63. South Korea digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 64. South Korea digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 65. Thailand digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 66. Thailand digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 67. Thailand digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 68. Latin America digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
  • Table 69. Latin America digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 70. Latin America digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 71. Latin America digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 72. Brazil digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 73. Brazil digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 74. Brazil digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 75. Argentina digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 76. Argentina digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 77. Argentina digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 78. MEA digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
  • Table 79. MEA digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 80. MEA digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 81. MEA digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 82. South Africa digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 83. South Africa digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 84. South Africa digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 85. Saudi Arabia digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 86. Saudi Arabia digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 87. Saudi Arabia digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 88. UAE digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 89. UAE digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 90. UAE digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 91. Kuwait digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 92. Kuwait digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 93. Kuwait digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)

List of Figures

  • Fig. 1. Information procurement
  • Fig. 2. Primary research pattern
  • Fig. 3. Market research approaches
  • Fig. 4. Value chain-based sizing & forecasting
  • Fig. 5. Market formulation & validation
  • Fig. 6. Digital neuro biomarkers market segmentation
  • Fig. 7. Market driver analysis (current & future impact)
  • Fig. 8. Market restraint analysis (current & future impact)
  • Fig. 9. SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10. Porter's five forces analysis
  • Fig. 11. Digital neuro biomarkers market, type outlook key takeaways (USD million)
  • Fig. 12. Digital neuro biomarkers market: type movement analysis (USD million), 2023 & 2030
  • Fig. 13. Wearable market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 14. Mobile based applications market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 15. Sensors market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 16. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 17. Digital neuro biomarkers market, clinical practice outlook key takeaways (USD million)
  • Fig. 18. Digital neuro biomarkers market: clinical practice movement analysis (USD million), 2023 & 2030
  • Fig. 19. Diagnostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 20. Monitoring psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 21. Predictive and prognostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 22. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 23. Digital neuro biomarkers market, end use outlook key takeaways (USD million)
  • Fig. 24. Digital neuro biomarkers market: end use movement analysis (USD million), 2023 & 2030
  • Fig. 25. Healthcare companies market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 26. Healthcare providers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 27. Payers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 28. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 29. Digital neuro biomarkers market: regional key takeaways (USD million)
  • Fig. 30. Digital neuro biomarkers market: regional outlook, 2023 & 2030, USD million
  • Fig. 31. North America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 32. U.S. Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 33. Canada Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 34. Mexico Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 35. Europe Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 36. UK Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 37. Germany Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 38. France Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 39. Spain Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 40. Italy Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 41. Norway Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 42. Denmark Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 43. Sweden Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 44. Asia Pacific Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 45. China Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 46. Japan Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 47. India Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 48. South Korea Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 49. Australia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 50. Thailand Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 51. Latin America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 52. Brazil Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 53. Argentina Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 54. Middle East and Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 55. South Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 56. Saudi Arabia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 57. UAE Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 58. Kuwait Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 59. List of key emerging company's/technology disruptors/innovators